7 a.m.

Pre-Conference Non-CME Lecture
LP(a) – A Novel Biomarker with Great Clinical Promise
Sotirios Tsimikas, MD

7:30 a.m.

Virtual Event Opens & View Exhibits

7:55 a.m.

Welcome and Introductions
David P. Cork, MD and Christopher J. Suhar, MD

8 a.m.

New Concepts in Dyslipidemia: Dispelling 10 Common Health “Truths” About Lipids and Risk Assessment
Douglas W. Triffon, MD

8:30 a.m.

Influence of Elevated Triglycerides on Atherosclerosis and Non-Statin Therapies - Review of Data: Omega 3, Bempedoic Acid, Niacin, Ezetimibe, PCSK9 Inhibitors
David P. Cork, MD

9 a.m.

Evaluation of Subclinical Coronary Atherosclerosis, Coronary CTA and Coronary Calcium Score
Jorge A. Gonzalez, MD

9:30 a.m.

Panel Discussion/Q&A

9:45 a.m.

Break & View Exhibits

10:05 a.m.

Exercise and Cardiovascular Risk
Christopher J. Suhar, MD

10:35 a.m.

Cardiovascular Prevention in Women
Poulina Q. Uddin, MD

11:05 a.m.

Optimizing Dietary Pattern in Patients with Cardiovascular Disease
Sandeep R. Mehta, MD

11:45 a.m.

Panel Discussion/Q&A

Noon

Break & View Exhibits

12:15 p.m.

Cardiometabolic Disease and Novel Therapies: SGLT2 Inhibitors and GLP1 Agonists
Daniel Einhorn, MD

12:45 p.m.

Update on Inflammation and Novel Biomarkers for Atherosclerosis
Douglas W. Triffon, MD

1:15 p.m.

The Utility of Polygenic Risk Scores in Primary Prevention of Atherosclerotic Cardiovascular Disease
Amitabh C. Pandey, MD

1:45 p.m.

Panel Discussion/Q&A

2 p.m.

Adjourn

2-3 p.m.

Non-CME Activity Hosted by Esperion
An Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C
Matthew Budoff, MD